Phase II trial of temozolomide (TMZ) followed by myeloablative chemotherapy with autologous peripheral blood progenitor cell rescue (APBPCR) for newly diagnosed anaplastic oligodendroglioma: An Oligodendroglioma Study Group trial Meeting Abstract

  

Authors:	Kaley, T. J.; Raizer, J. J.; Paleologos, N.; Kewalramani, T.; Grimm, S.; Louis, D. N.; Cairncross, J. G.; Abrey, L. E.
Abstract Title:	Phase II trial of temozolomide (TMZ) followed by myeloablative chemotherapy with autologous peripheral blood progenitor cell rescue (APBPCR) for newly diagnosed anaplastic oligodendroglioma: An Oligodendroglioma Study Group trial
Meeting Title:	45th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	27
Issue:	15 Suppl.
Meeting Dates:	2009 May 29-Jun 2
Meeting Location:	Orlando, FL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2009-05-20
Start Page:	100s
Language:	English
ACCESSION:	WOS:000276606602203
PROVIDER:	wos
DOI:	10.1200/jco.2009.27.15_suppl.2055
Notes:	Meeting Abstract: 2055 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/129663